Literature DB >> 17768256

Selection of transposon mutants of Mycobacterium tuberculosis with increased macrophage infectivity identifies fadD23 to be involved in sulfolipid production and association with macrophages.

Jennifer Lynett1, Richard W Stokes2.   

Abstract

Alterations to the composition or architecture of the mycobacterial cell envelope can affect the macrophage infectivity of the bacillus. To further characterize the mycobacterial gene products that modulate the interaction with host cells, we employed transposon mutagenesis and screened for mutants that demonstrated an enhanced binding affinity toward macrophages. After successive rounds of mutant selection and enrichment, a total of five mutants were isolated that harboured gene disruptions within loci involved in lipid synthetic pathways as well as genes coding for putative hypothetical proteins. One mutant in particular, with a disruption in the Rv3826 gene (fadD23), was repeatedly isolated during library screening. Analysis of the cell envelope constituents of the Tn : : fadD23 strain revealed a lack of sulfolipid production which was restored following complementation with the wild-type gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17768256     DOI: 10.1099/mic.0.2007/007864-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  14 in total

1.  Deciphering sulfoglycolipids of Mycobacterium tuberculosis.

Authors:  Emilie Layre; Diane Cala-De Paepe; Gérald Larrouy-Maumus; Julien Vaubourgeix; Sathish Mundayoor; Buko Lindner; Germain Puzo; Martine Gilleron
Journal:  J Lipid Res       Date:  2011-04-11       Impact factor: 5.922

2.  Identification of valine- or leucine-containing glycopeptidolipids from Mycobacterium avium-intracellulare complex.

Authors:  Naoya Ichimura; Takeshi Kasama
Journal:  Curr Microbiol       Date:  2012-03-22       Impact factor: 2.188

3.  Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-coenzyme A synthetase gene fadD5.

Authors:  Kathleen Y Dunphy; Ryan H Senaratne; Mamiko Masuzawa; Lon V Kendall; Lee W Riley
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

4.  Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.

Authors:  Marzena Baran; Kimberly D Grimes; Paul A Sibbald; Peng Fu; Helena I M Boshoff; Daniel J Wilson; Courtney C Aldrich
Journal:  Eur J Med Chem       Date:  2020-06-13       Impact factor: 6.514

5.  A high-throughput screening fluorescence polarization assay for fatty acid adenylating enzymes in Mycobacterium tuberculosis.

Authors:  Kimberly D Grimes; Courtney C Aldrich
Journal:  Anal Biochem       Date:  2011-07-02       Impact factor: 3.365

6.  Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.

Authors:  Mamadou Daffé; Dean C Crick; Mary Jackson
Journal:  Microbiol Spectr       Date:  2014

7.  Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.

Authors:  Olga Danilchanka; Claudia Mailaender; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

Review 8.  The cell envelope glycoconjugates of Mycobacterium tuberculosis.

Authors:  Shiva Kumar Angala; Juan Manuel Belardinelli; Emilie Huc-Claustre; William H Wheat; Mary Jackson
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-06-10       Impact factor: 8.250

9.  Diversity of Mycobacterium tuberculosis across Evolutionary Scales.

Authors:  Mary B O'Neill; Tatum D Mortimer; Caitlin S Pepperell
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

10.  Genomic and proteomic analyses of Mycobacterium bovis BCG Mexico 1931 reveal a diverse immunogenic repertoire against tuberculosis infection.

Authors:  Patricia Orduña; Miguel A Cevallos; Samuel Ponce de León; Adriana Arvizu; Ismael L Hernández-González; Guillermo Mendoza-Hernández; Yolanda López-Vidal
Journal:  BMC Genomics       Date:  2011-10-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.